European investors have shown strong interest in Antisense Therapeutics Limited (ASX: ANP: FWB: AWY) since the company was dual listed in...

Antisense Therapeutics (ASX: ANP) and (FRA: AWY) are up over 60% in 2 months. 2 major reasons for this: Sarpeta Therapeutics announced...

As the 2020 year of biotech investing draws to a close, mRNA technology stands out as the defining technology of the decade. Never before...

2020 was the first year that investment in ESG-oriented funds hit the USD 1 trillion figure (according to FT Advisor). However, Morgan...

Australian based innovative biotech company, Antisense Therapeutics Limited (ASX: ANP) and (FRA: AWY) received a strong brokers...

RNA is the target that forms the basis of Ionis's Pharmaceuticals (FRA: ISI) and (NASDAQ: IONS) novel drug discovery platform, The...

The recent news that BioNTech and Pfizer’s Covid-19 vaccine was more than 90 per cent effective in clinical trials has increased...

An exciting and innovative Australian biotech - Antisense Therapeutics Limited (ASX: ANP) and (FRA: AWY) has now listed on the Frankfurt...